Canada Life’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-23,552
| Closed | -$38K | – | 2272 |
|
2023
Q1 | $38K | Buy |
23,552
+20,546
| +683% | +$33.2K | ﹤0.01% | 2107 |
|
2022
Q4 | $19K | Buy |
+3,006
| New | +$19K | ﹤0.01% | 2260 |
|
2021
Q4 | – | Sell |
-1,660
| Closed | -$20K | – | 2522 |
|
2021
Q3 | $20K | Hold |
1,660
| – | – | ﹤0.01% | 2438 |
|
2021
Q2 | $35K | Hold |
1,660
| – | – | ﹤0.01% | 2362 |
|
2021
Q1 | $46K | Hold |
1,660
| – | – | ﹤0.01% | 2319 |
|
2020
Q4 | $43K | Hold |
1,660
| – | – | ﹤0.01% | 2336 |
|
2020
Q3 | $62K | Hold |
1,660
| – | – | ﹤0.01% | 2136 |
|
2020
Q2 | $85K | Hold |
1,660
| – | – | ﹤0.01% | 2090 |
|
2020
Q1 | $53K | Hold |
1,660
| – | – | ﹤0.01% | 2112 |
|
2019
Q4 | $98K | Hold |
1,660
| – | – | ﹤0.01% | 2073 |
|
2019
Q3 | $61K | Sell |
1,660
-1,468
| -47% | -$53.9K | ﹤0.01% | 1031 |
|
2019
Q2 | $145K | Hold |
3,128
| – | – | ﹤0.01% | 2110 |
|
2019
Q1 | $125K | Hold |
3,128
| – | – | ﹤0.01% | 1995 |
|
2018
Q4 | $139K | Hold |
3,128
| – | – | ﹤0.01% | 2036 |
|
2018
Q3 | $139K | Hold |
3,128
| – | – | ﹤0.01% | 2090 |
|
2018
Q2 | $123K | Hold |
3,128
| – | – | ﹤0.01% | 2123 |
|
2018
Q1 | $227K | Hold |
3,128
| – | – | ﹤0.01% | 1932 |
|
2017
Q4 | $206K | Buy |
3,128
+1,828
| +141% | +$120K | ﹤0.01% | 1958 |
|
2017
Q3 | $65K | Hold |
1,300
| – | – | ﹤0.01% | 2269 |
|
2017
Q2 | $60K | Hold |
1,300
| – | – | ﹤0.01% | 2269 |
|
2017
Q1 | $46K | Hold |
1,300
| – | – | ﹤0.01% | 2323 |
|
2016
Q4 | $16K | Hold |
1,300
| – | – | ﹤0.01% | 2506 |
|
2016
Q3 | $18K | Hold |
1,300
| – | – | ﹤0.01% | 2470 |
|
2016
Q2 | $13K | Hold |
1,300
| – | – | ﹤0.01% | 2493 |
|
2016
Q1 | $22K | Hold |
1,300
| – | – | ﹤0.01% | 2333 |
|
2015
Q4 | $29K | Hold |
1,300
| – | – | ﹤0.01% | 2305 |
|
2015
Q3 | $31K | Hold |
1,300
| – | – | ﹤0.01% | 2246 |
|
2015
Q2 | $106K | Hold |
1,300
| – | – | ﹤0.01% | 1827 |
|
2015
Q1 | $120K | Buy |
+1,300
| New | +$120K | ﹤0.01% | 1680 |
|